These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27462461)

  • 1. A genome-scale CRISPR-Cas9 screening method for protein stability reveals novel regulators of Cdc25A.
    Wu Y; Zhou L; Wang X; Lu J; Zhang R; Liang X; Wang L; Deng W; Zeng YX; Huang H; Kang T
    Cell Discov; 2016; 2():16014. PubMed ID: 27462461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein stability regulators screening assay (Pro-SRSA): protein degradation meets the CRISPR-Cas9 library.
    Wu Y; Kang T
    Chin J Cancer; 2016 Jun; 35(1):60. PubMed ID: 27357860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone acetyltransferase CBP promotes function of SCF FBXL19 ubiquitin E3 ligase by acetylation and stabilization of its F-box protein subunit.
    Wei J; Dong S; Yao K; Martinez MFYM; Fleisher PR; Zhao Y; Ma H; Zhao J
    FASEB J; 2018 Aug; 32(8):4284-4292. PubMed ID: 29522376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylation and deacetylation of Cdc25A constitutes a novel mechanism for modulating Cdc25A functions with implications for cancer.
    Lozada EM; Andrysik Z; Yin M; Redilla N; Rice K; Stambrook PJ
    Oncotarget; 2016 Apr; 7(15):20425-39. PubMed ID: 26967250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-focused CRISPR-Cas9 library screen reveals fitness-associated miRNAs.
    Kurata JS; Lin RJ
    RNA; 2018 Jul; 24(7):966-981. PubMed ID: 29720387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kaposi's Sarcoma-Associated Herpesvirus LANA Modulates the Stability of the E3 Ubiquitin Ligase RLIM.
    Tadmor H; Greenway M; Ahuja A; Orgil O; Liao G; Ambinder RF; Hayward SD; Shamay M
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31801865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-scale screening of deubiquitinase subfamily identifies USP3 as a stabilizer of Cdc25A regulating cell cycle in cancer.
    Das S; Chandrasekaran AP; Suresh B; Haq S; Kang JH; Lee SJ; Kim J; Kim J; Lee S; Kim HH; Kim KS; Ramakrishna S
    Cell Death Differ; 2020 Nov; 27(11):3004-3020. PubMed ID: 32415280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Functional genetic screening using CRISPR-Cas9 system].
    Li H; Huang C
    Sheng Wu Gong Cheng Xue Bao; 2018 Apr; 34(4):461-472. PubMed ID: 29701021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIAH-mediated ubiquitination and degradation of acetyl-transferases regulate the p53 response and protein acetylation.
    Grishina I; Debus K; García-Limones C; Schneider C; Shresta A; García C; Calzado MA; Schmitz ML
    Biochim Biophys Acta; 2012 Dec; 1823(12):2287-96. PubMed ID: 23044042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput screens in mammalian cells using the CRISPR-Cas9 system.
    Peng J; Zhou Y; Zhu S; Wei W
    FEBS J; 2015 Jun; 282(11):2089-96. PubMed ID: 25731961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress on genome-wide CRISPR/Cas9 screening for functional genes and regulatory elements.
    Liu SY; Yi GQ; Tang ZL; Chen B
    Yi Chuan; 2020 May; 42(5):435-443. PubMed ID: 32431295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying synthetic lethal targets using CRISPR/Cas9 system.
    Dhanjal JK; Radhakrishnan N; Sundar D
    Methods; 2017 Dec; 131():66-73. PubMed ID: 28710008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A high-throughput screening strategy for detecting CRISPR-Cas9 induced mutations using next-generation sequencing.
    Bell CC; Magor GW; Gillinder KR; Perkins AC
    BMC Genomics; 2014 Nov; 15(1):1002. PubMed ID: 25409780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipopolysaccharide modulates p300 and Sirt1 to promote PRMT1 stability via an SCF
    Lai Y; Li J; Li X; Zou C
    J Cell Sci; 2017 Oct; 130(20):3578-3587. PubMed ID: 28883095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of drug-inducible CRISPR-Cas9 systems for large-scale functional screening.
    Sun N; Petiwala S; Wang R; Lu C; Hu M; Ghosh S; Hao Y; Miller CP; Chung N
    BMC Genomics; 2019 Mar; 20(1):225. PubMed ID: 30890156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRL4B
    Liu F; Cao L; Zhang T; Chang F; Xu Y; Li Q; Deng J; Li L; Shao G
    Biochem Biophys Res Commun; 2018 Jun; 501(2):440-447. PubMed ID: 29738775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening.
    Joung J; Konermann S; Gootenberg JS; Abudayyeh OO; Platt RJ; Brigham MD; Sanjana NE; Zhang F
    Nat Protoc; 2017 Apr; 12(4):828-863. PubMed ID: 28333914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylation-dependent regulation of MDM2 E3 ligase activity dictates its oncogenic function.
    Nihira NT; Ogura K; Shimizu K; North BJ; Zhang J; Gao D; Inuzuka H; Wei W
    Sci Signal; 2017 Feb; 10(466):. PubMed ID: 28196907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual-function chromogenic screening-based CRISPR/Cas9 genome editing system for actinomycetes.
    Wang Q; Xie F; Tong Y; Habisch R; Yang B; Zhang L; Müller R; Fu C
    Appl Microbiol Biotechnol; 2020 Jan; 104(1):225-239. PubMed ID: 31788711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani.
    Zhang WW; Matlashewski G
    mBio; 2015 Jul; 6(4):e00861. PubMed ID: 26199327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.